News

National report - Chandra, Jordan and Trae Berns have carried severe scars over much of their bodies since the 22-year-old triplets suffered third-degree burns in a house fire at the age of 17 months.

Washington - The Food and Drug Administration has acknowledged receipt of Sol-Gel’s Investigational New Drug Application (IND) for DER45-EV Gel for the topical treatment of rosacea, reports Medical News Today.

Berkeley Heights, N.J. - Pharmaceutical company Genta Inc., based here, announced recently that a phase 3 drug trial for the melanoma drug Genasense showed no statistically significant benefit compared with a placebo, reports news source Foxbusiness.com.

Cleveland - The National Institutes of Health has awarded Pratima Karnik, Ph.D., assistant professor of dermatology at Cleveland’s Case Western Reserve University, a grant of $1.77 million to fund a five-year study titled “PPAR-gamma Signaling in Normal Pilosebaceous Units and in Scarring Alopecia,” reports the Cicatricial Alopecia Research Foundation (CARF).

Minneapolis - Results of a recently completed study appear to establish the efficacy of Levulan Photodynamic Therapy (PDT) in reducing the recurrence of squamous cell carcinomas (SCCs) in solid organ transplant recipients (SOTRs), reports PRNewswire.

Be’er Sheva, Israel - A new Israeli invention allows cancerous skin tumors to be detected and examined before they become visible to the naked eye, reports news source Haaretz.com.

London - Researchers from Cancer Research UK's Cambridge Research Institute say they have found how two genes from the same “family” can interact to stop cancer, reports News-medical.net.

The entire financial world was turned upside down during the years 2008 and 2009. Investors, executives, employees and the general public are left wondering, "Whom can I trust?" and "How will all these changes affect me?"

Developments that link HPV to skin cancer could change the frontiers of medicine.

Investigators have found that a particular nicotinic acid receptor has increased expression in later stages of SCC, indicating that this receptor may represent a target for therapy in nonmelanoma skin cancer.

Physicians' efforts to collect from patients are exponentially better nowadays, but patient statements haven't changed in decades: a slip of paper is popped into an envelope and mailed every 30 days. In this volatile, changing economy, it's time to overhaul your dermatology practice's approach to patient statements.

Treatment of melomental fold rhytids with both Botox and an HA filler affords long-lasting results.

With the House and Senate attempting to advance differing visions of healthcare reform, a long-term fix for Medicare's broken sustainable growth rate (SGR) formula hangs in the balance, dermatologists say.

In humans, rare animal-type melanoma variant seems to be more bark than bite.

William Baugh, M.D., was a liberal arts student at Westmont College, Santa Barbara, Calif., when he first volunteered for an outreach trip to help less-fortunate people in Mexico. That decision ultimately was the springboard to a future in medicine.

While the worst economic slump in decades has sharply cut into consumer demand for æsthetic products, at least one analyst says there's reason to anticipate a bounceback in the coming months.

Dr. Privacy has been a practicing dermatologist for 30 years. He has prided himself on being computer savvy, and tries to keep abreast of the latest in legal requirements that impact his practice. Most of his patients are on a variety of managed care insurance plans.

A recent clinical trial found that the dietary supplementation of oral zinc sulfate is ineffective in treating patients suffering from moderate-to-severe rosacea. The apparent failure of this particular clinical trial is of particular interest in that it was a near-duplicate of a 3-year-old clinical trial found in the literature, which showed that oral zinc supplementation was beneficial in the treatment of rosacea.

In healthcare reform discussions, there is an emphasis on primary care. We wondered what dermatologists think of this, and whether this could diminish specialty practices and/or impact patient care.

Few controlled studies are available for the treatment of atopic dermatitis, so physicians must rely on experience.

A more precise skin typing system using diffuse reflectance spectrometry is beneficial to those with intermediate skin types.

Standard dressings rein in woundcare, but new research is uncovering innovative therapies for certain conditions

Custom-matched self-service facial foundations are based on the concept of color and tone and requires the use of two products.

In September 2009, Amgen decided to withdraw application for expanded use of its biologic tumor necrosis factor (TNF) blocking agent etanercept (Enbrel) in pediatric patients with moderate-to-severe psoriasis.

Gene and stem cell research is showing promise for the treatment of chronic wounds

Many factors guide decisions on choice of appropriate closure

The treatment of chronic wounds simulates an entire industry of products - including laser devices.

It has become increasingly likely that even if Congress approves some form of healthcare reform this year or early next, it will not include significant reform of the formula on which physician Medicare payments are calculated, which is disappointing news for dermatologists and every physician who serves Medicare patients.

Six patients with corticosteroid-dependant bullous pemphigoid discontinued prednisone or tapered to a low daily dose after treatment with rituximab (Rituxan, Genentech)

San Antonio - Army Capt. Christopher Collins, M.D., a staff dermatologist at Wilford Hall Medical Center, says he saw what every dermatologist sees - only worse - during his recent seven-month deployment to Iraq.